Alison Bladh
MARCH 25, 2025
This is a question I get asked a lot by clients, particularly women over 40 navigating perimenopause and menopause. Many have begun using topical oestrogen creams to relieve menopausal symptoms, only to notice new moles or increased pigmentation appearing on their skin. Naturally, this can feel worrying and raises the questionis there a connection? Lets explore what we know.
The Dermatology Digest
MARCH 25, 2025
Meet riSCC, a new data-driven app designed for risk stratification of cutaneous squamous cell carcinoma (cSCC) in clinical settings. Launched by the not-for-profit organization Skin Cancer Consortium Outcomes (SCOUT), riSCC is built from a multinational study of over 20,000 tumors. It will be used by clinicians to analyze patient and tumor characteristics to generate an evidence-based risk score for predicting cSCC outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Spa Industry Association
MARCH 25, 2025
Ultraluxe Caviar Collagen Eye Cream with 9% Biomimetic Peptides and The Black Label Fountain of Youth Facial are designed to sculpt, lift, and illuminate (New York, NY) March 18, 2025 Savor Beauty, the clean beauty brand known for blending Korean rituals with New York luxury, announced the launch of its highly anticipated Black Label Caviar Collagen Eye Cream and new ultraluxe facial protocol The Black Label Fountain of Youth.
West Lake Dermatology
MARCH 25, 2025
Coenzyme Q10, commonly known as CoQ10, is a naturally occurring antioxidant found in nearly every cell of the human body. It plays a crucial role in cellular energy production, helping to generate adenosine triphosphate (ATP), the molecule responsible for storing and distributing energy. This energy is essential for the proper functioning of all cells, including skin cells, which require ATP to maintain a healthy, youthful appearance.
Trillium Creek Dermatology
MARCH 25, 2025
As spring arrives in Ohio, the warmer weather brings new challenges for our skin. Increased humidity and sun exposure can lead to oilier skin, breakouts, and exacerbated conditions like rosacea. However, with the latest advancements in dermatological treatments, achieving radiant and healthy skin is more accessible than ever. One such innovative solution is the Aerolase treatment, which offers a non-invasive and effective way to address common skin concerns such as acne and rosacea.
The Dermatology Digest
MARCH 25, 2025
LetibotulinumtoxinA-wlbg (Letybo, Hugel & Benev) is now fully commercialized in the U.S. “We are honored to join forces with Hugel to bring Letybo to the U.S. market,” says Ethan Min, Chief Executive Officer at BENEV, in a news release. “This partnership with Hugel allows us to strengthen our market position and fulfill our mission to BENefit EVeryone through transformative aesthetic solutions.” LetibotulinumtoxinA is the No. 1 neuromodulator in South Korea.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Dermatology Digest
MARCH 25, 2025
The WHO Foundation and the LOral Groupe , spearheaded by its Dermatological Beauty Division, are launching a four-year partnership to expand access to the treatment of skin conditions worldwide. With a focus on low- and middle-income settings, the partnership will accelerate the World Health Organizations (WHOs) efforts to support countries to address skin conditions such as those caused by neglected tropical diseases (NTDs), those exacerbated by climate change and other common conditions such a
Dermatology Times
MARCH 25, 2025
Each treatment had benefits and disadvantages for patients who struggle with rosacea-associated erythema.
Salon Today
MARCH 25, 2025
Want to boost client loyalty and drive more revenue? Discover 7 proven strategies to keep your salon guests coming back. From pre-booking tactics to personalized retail experiences, this guide is packed with insights to help you strengthen customer retention and grow your business.
Dermatology Times
MARCH 25, 2025
The novel treatments will be for patients with orphan conditions like Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, and palmoplantar keratoderma.
Salon Today
MARCH 25, 2025
Are your profit margins razor thin? This guide can help. Get expert insights you can start using right away.
Dermatology Times
MARCH 25, 2025
Research suggests that neomycin allergy may be underdiagnosed despite its common use in medical and cosmetic formulations.
Salon Today
MARCH 25, 2025
Discover how Organethic Pure Cares Head SPA treatment combines advanced techniques and natural products to offer a unique experience of wellness and regeneration for your scalp and hair.
Dermatology Times
MARCH 25, 2025
Panelists discuss how generalized pustular psoriasis (GPP), while rare, presents with distinctive widespread sterile pustules on erythematous skin, requires prompt medical intervention, and differs significantly from more common plaque psoriasis in its clinical presentation, triggers, and treatment approaches.
Dermatology Times
MARCH 25, 2025
Panelists discuss how clinical experience in diagnosing generalized pustular psoriasis (GPP) requires recognizing its hallmark features of widespread sterile pustules on inflamed skin, distinguishing it from other pustular conditions, and understanding the genetic mutations and triggers that can precipitate this rare but potentially life-threatening form of psoriasis.
Dermatology Times
MARCH 25, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Dermatology Times
MARCH 25, 2025
An expert panel of clinicians provided insights on first-line treatments, maintenance strategies, and flare management for AD.
Dermatology Times
MARCH 25, 2025
Mercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.
Dermatology Times
MARCH 25, 2025
Nanoneedles boosted CRISPR base editing efficiency in RDEB fibroblasts, enabling precise COL7A1 correction and improved cell function.
Dermatology Times
MARCH 25, 2025
A study reveals that biologics targeting IL-12, IL-23, and IL-17 lower the risk of serious infections in older adults with psoriatic disease.
Expert insights. Personalized for you.
92 
Let's personalize your content